Open AccessBIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS
Author(s) -
E. Pyadushkina
Publication year - 2017
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2017.10.1.019-028
Subject(s) - vedolizumab , medicine , ulcerative colitis , crohn's disease , disease , adalimumab , infliximab , inflammatory bowel disease , intensive care medicine